The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System
- 11 September 2009
- journal article
- research article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 12 (2) , 179-192
Abstract
The complement system is a pivotal component of the innate immune system which protects the host from infection and injury. Complement proteins can be induced in all cell types within the central nervous system (CNS), where the pathway seems to play similar roles in host defense. Complement activation produces the C5 cleavage fragment C5a, a potent inflammatory mediator, which recruits and activates immune cells. The primary cellular receptor for C5a, the C5a receptor (CD88), has been reported to be on all CNS cells, including neurons and glia, suggesting a functional role for C5a in the CNS. A second receptor for C5a, the C5a-like receptor 2 (C5L2), is also expressed on these cells; however, little is currently known about its potential role in the CNS. The potent immune and inflammatory actions of complement activation are necessary for host defense. However, if over-activated, or left unchecked it promotes tissue injury and contributes to brain disease pathology. Thus, complement activation, and subsequent C5a generation, is thought to play a significant role in the progression of CNS disease. Paradoxically, complement may also exert a neuroprotective role in these diseases by aiding in the elimination of aggregated and toxic proteins and debris which are a principal hallmark of many of these diseases. This review will discuss the expression and known roles for complement in the CNS, with a particular focus on the pro-inflammatory end-product, C5a. The possible overarching role for C5a in diseases of the CNS is reviewed, and the therapeutic potential of blocking C5a/CD88 interaction is evaluated.Keywords
This publication has 146 references indexed in Scilit:
- Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhageBrain Research, 2009
- Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: Quantification of migration by a novel near‐infrared methodGlia, 2008
- Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s diseaseJournal of Neurochemistry, 2008
- Functional roles for C5a receptors in sepsisNature Medicine, 2008
- C5 deficiency and C5a or C5aR blockade protects against cerebral malariaJournal of Experimental Medicine, 2008
- Complement-targeted therapeuticsNature Biotechnology, 2007
- Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neuronsProceedings of the National Academy of Sciences, 2007
- Studies on the interactions between C‐reactive protein and complement proteinsImmunology, 2007
- Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysJournal of Experimental Medicine, 2006
- Complement activation in amyloid plaques in Alzheimer’s dementiaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988